MEDP logo

Medpace Holdings (MEDP) Company Overview

Profile

Full Name:

Medpace Holdings, Inc.

Sector:

Healthcare

Country:

United States

IPO:

August 11, 2016

Indexes:

Not included

Description:

Medpace Holdings, Inc. specializes in conducting contract clinical research for companies in the biotechnology, pharmaceutical, and medical industries. It was founded in 1992. The headquarters is located in Cincinnati, Ohio (USA). Medpace Holdings, Inc. provides a wide range of services: monitoring clinical trials, laboratory analysis, electronic data capture, patient recruitment, and more. The company conducts scientific research on new drugs and medical devices in key therapeutic areas such as cardiology, hematology, oncology, neurology and psychiatry, vaccine development, antibiotics, etc. Clients of Medpace Holdings, Inc. include many leading global pharmaceutical, biotechnology companies, and medical device manufacturers.

Key Details

Price

$360.97

Annual Revenue

$1.89 B(+29.17% YoY)

Annual EPS

$8.88(+21.98% YoY)

Beta

1.16

Events Calendar

Earnings

Next earnings date:

Feb 10, 2025

Recent quarterly earnings:

Oct 21, 2024

Recent annual earnings:

Feb 12, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 27, 25 Baird
Neutral
Nov 25, 24 Baird
Neutral
Oct 23, 24 TD Cowen
Buy
Oct 23, 24 Baird
Neutral
Oct 22, 24 William Blair
Outperform
Oct 14, 24 Truist Securities
Hold
Oct 14, 24 Redburn Atlantic
Buy
Sep 27, 24 UBS
Neutral
Sep 25, 24 Jefferies
Hold
Sep 20, 24 Baird
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

Medpace: Impressive Revenue Growth, High ROE Values, And High Growth Potential
Medpace: Impressive Revenue Growth, High ROE Values, And High Growth Potential
Medpace: Impressive Revenue Growth, High ROE Values, And High Growth Potential
MEDP
seekingalpha.comFebruary 5, 2025

Medpace has shown strong financial results, with a revenue increase of 495.26% from the second quarter of 2016 to the third quarter of 2024. The company's current return on equity (ROE) stands at 54.08%, and it has successfully targeted small and mid-sized businesses, gaining a competitive edge in this area. Even though Medpace has faced significant cancellations in its backlog, it remains a robust company, achieving a growth rate of 9.81% from 2023 to the third quarter of 2024.

Medpace (MEDP) Falls More Steeply Than Broader Market: What Investors Need to Know
Medpace (MEDP) Falls More Steeply Than Broader Market: What Investors Need to Know
Medpace (MEDP) Falls More Steeply Than Broader Market: What Investors Need to Know
MEDP
zacks.comFebruary 3, 2025

At the end of the last trading day, Medpace (MEDP) was priced at $343.38, which represents a decrease of 1.65% compared to the day before.

The Schall Law Firm Invites Shareholders With Losses To Join An Investigation Into Medpace Holdings, Inc. For Securities Fraud
The Schall Law Firm Invites Shareholders With Losses To Join An Investigation Into Medpace Holdings, Inc. For Securities Fraud
The Schall Law Firm Invites Shareholders With Losses To Join An Investigation Into Medpace Holdings, Inc. For Securities Fraud
MEDP
accessnewswire.comFebruary 2, 2025

LOS ANGELES, CA / ACCESS Newswire / February 2, 2025 / The Schall Law Firm, a national firm that represents shareholders, is looking into claims for investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements or did not share important information with investors.

Medpace Holdings, Inc. Is Being Investigated For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm
Medpace Holdings, Inc. Is Being Investigated For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm
Medpace Holdings, Inc. Is Being Investigated For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm
MEDP
accessnewswire.comFebruary 1, 2025

LOS ANGELES, CA / ACCESS Newswire / February 1, 2025 / The Schall Law Firm, a national firm specializing in shareholder rights, is looking into claims for investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements or did not share important information with investors.

Medpace (MEDP) Ascends While Market Falls: Some Facts to Note
Medpace (MEDP) Ascends While Market Falls: Some Facts to Note
Medpace (MEDP) Ascends While Market Falls: Some Facts to Note
MEDP
zacks.comJanuary 27, 2025

In the most recent trading session, Medpace (MEDP) finished at $350.37, which is an increase of 1.83% compared to the day before.

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Medpace Holdings, Inc. For Securities Law Violations
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Medpace Holdings, Inc. For Securities Law Violations
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Medpace Holdings, Inc. For Securities Law Violations
MEDP
accessnewswire.comJanuary 27, 2025

LOS ANGELES, CA / ACCESS Newswire / January 27, 2025 / The Schall Law Firm, a national firm that represents shareholders, is looking into claims for investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements and/or did not share important information with investors.

Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm
Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm
Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm
MEDP
accessnewswire.comJanuary 26, 2025

LOS ANGELES, CA / ACCESS Newswire / January 26, 2025 / The Schall Law Firm, a national firm that represents shareholders, is looking into claims for investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements or did not share important information with investors.

Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm
Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm
Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm
MEDP
accessnewswire.comJanuary 23, 2025

LOS ANGELES, CA / ACCESS Newswire / January 23, 2025 / The Schall Law Firm, a national firm specializing in shareholder rights, is looking into claims for investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements and/or did not share important information with investors.

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Medpace Holdings, Inc. For Securities Law Violations
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Medpace Holdings, Inc. For Securities Law Violations
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Medpace Holdings, Inc. For Securities Law Violations
MEDP
accessnewswire.comJanuary 22, 2025

LOS ANGELES, CA / ACCESS Newswire / January 22, 2025 / The Schall Law Firm, a national firm specializing in shareholder rights, is looking into claims for investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements or did not share important information with investors.

Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm
Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm
Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm
MEDP
accessnewswire.comJanuary 21, 2025

LOS ANGELES, CA / ACCESS Newswire / January 21, 2025 / The Schall Law Firm, a national firm specializing in shareholder rights, is looking into claims for investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements or did not share important information with investors.

FAQ

  • What is the ticker symbol for Medpace Holdings?
  • Does Medpace Holdings pay dividends?
  • What sector is Medpace Holdings in?
  • What industry is Medpace Holdings in?
  • What country is Medpace Holdings based in?
  • When did Medpace Holdings go public?
  • Is Medpace Holdings in the S&P 500?
  • Is Medpace Holdings in the NASDAQ 100?
  • Is Medpace Holdings in the Dow Jones?
  • When was Medpace Holdings's last earnings report?
  • When does Medpace Holdings report earnings?
  • Should I buy Medpace Holdings stock now?

What is the ticker symbol for Medpace Holdings?

The ticker symbol for Medpace Holdings is NASDAQ:MEDP

Does Medpace Holdings pay dividends?

No, Medpace Holdings does not pay dividends

What sector is Medpace Holdings in?

Medpace Holdings is in the Healthcare sector

What industry is Medpace Holdings in?

Medpace Holdings is in the Diagnostics & Research industry

What country is Medpace Holdings based in?

Medpace Holdings is headquartered in United States

When did Medpace Holdings go public?

Medpace Holdings's initial public offering (IPO) was on August 11, 2016

Is Medpace Holdings in the S&P 500?

No, Medpace Holdings is not included in the S&P 500 index

Is Medpace Holdings in the NASDAQ 100?

No, Medpace Holdings is not included in the NASDAQ 100 index

Is Medpace Holdings in the Dow Jones?

No, Medpace Holdings is not included in the Dow Jones index

When was Medpace Holdings's last earnings report?

Medpace Holdings's most recent earnings report was on Oct 21, 2024

When does Medpace Holdings report earnings?

The next expected earnings date for Medpace Holdings is Feb 10, 2025

Should I buy Medpace Holdings stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions